Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System [NA]

View source ↗

Summary

The study is recruiting to evaluate repeat ablation using the FARAPULSE Pulsed Field Ablation System for persistent atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FARAPULSE Pulsed Field Ablation System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Persistent Atrial Fibrillation | NA | Status: RECRUITING